Why Is Plus Therapeutics Stock (PSTV) Up 100% Today?
Plus Therapeutics (PSTV) stock saw a huge rally on Wednesday as the clinical-stage pharmaceutical company received approval from the Food and Drug Administration (FDA) for its Investigational New Drug (IND) application for REYOBIQ.
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
This approval covers the use of REYOBIQ as a potential treatment for pediatric patients with supratentorial recurrent, refractory, or progressive high-grade glioma (HGG) and ependymoma. The company will conduct a clinical trial of this, with the U.S. Department of Defense providing a $3 million grant to fund the study.
PSTV stock was up 103.69% in pre-market trading on Wednesday, following a 1.47% rally yesterday. However, the shares are down 83.74% year-to-date and have seen much volatility in 2025. This makes the stock a dangerous gambit not fit for risk-averse traders.
Is Plus Therapeutics Stock a Buy, Sell, or Hold?
Turning to Wall Street, the analysts' consensus rating for Plus Therapeutics is Strong Buy, based on three Buy and one Hold rating over the past three months. With that comes an average PSTV stock price target of $10, representing a potential 5,247.59% upside for the shares.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Verizon announces Semtech as ‘Verizon Frontline Verified' partner
Verizon (VZ) Frontline announced that several products from Semtech (SMTC), formerly Sierra Wireless, have achieved 'Verizon Frontline Verified' status. This includes the AirLink XR60 5G Router, which supports the recently-launched Verizon Frontline Network Slice. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders' Hot Stocks on TipRanks >> Read More on VZ: Disclaimer & DisclosureReport an Issue Verizon Business, Nokia to deploy Private 5G Networks along the River Thames Verizon Finalizes Private Exchange Offers for Notes Moderately bullish activity in Verizon with shares up 0.64% Verizon announces final results of private exchange offers Verizon Announces Results of Private Exchange Offers Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Lifeward prices 4M shares at 65c in public offering
Lifeward (LFWD) announced the pricing of a public offering of an aggregate of 4,000,000 of the Company's ordinary shares and accompanying warrants to purchase up to 4,000,000 of the Company's ordinary shares, at a combined public offering price of $0.65 per ordinary share and associated ordinary warrant. The ordinary warrants will have an exercise price of $0.65 per ordinary share, will be exercisable immediately upon issuance and will expire on the five-year anniversary of the issuance date. The closing of the offering is expected to occur on or about June 26, 2025, subject to the satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering. The aggregate gross proceeds to the Company from the offering are expected to be approximately $2.6M before deducting the placement agent's fees and other offering expenses payable by the Company. The potential additional gross proceeds to the Company from the ordinary warrants, if fully exercised on a cash basis, will be approximately $2.6M. The Company intends to use the net proceeds from this offering for its continuing commercial efforts, working capital and general corporate purposes. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on LFWD: Disclaimer & DisclosureReport an Issue Lifeward Announces Annual Meeting Date for 2025 Lifeward Announces New CEO Appointment Effective June 2025 Lifeward appoints Grant as new President, CEO Lifeward Ltd. Reports Q1 2025 Financial Results Lifeward Inc. Earnings Call: Optimism Amid Challenges
Yahoo
an hour ago
- Yahoo
Robin Energy prices 1.02M shares at $3.50 in registered direct offering
Robin Energy (RBNE) has entered into a securities purchase agreement with several institutional investors to purchase 1,020,000 common shares at an offering price of $3.50, for gross proceeds of approximately $3.6M, before deducting commissions and offering expenses, in a registered direct offering. Maxim Group is acting as the sole placement agent for the Offering. Robin Energy currently intends to use the net proceeds from the Offering for working capital and general corporate purposes. The Offering is expected to close on or about June 25, 2025, subject to the satisfaction of customary closing conditions. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on RBNE: Disclaimer & DisclosureReport an Issue Robin Energy Ltd. Secures $4.0 Million in Direct Offering Robin Energy prices 763,000 shares at $5.25 in registered direct offering Robin Energy Ltd. Secures $4.5 Million in Direct Offering Robin Energy Ltd trading resumes Robin Energy Ltd trading halted, volatility trading pause Sign in to access your portfolio
